Nanobiosensor Reports on CDK1 Kinase Activity in Tumor Xenografts in Mice

被引:6
|
作者
Tilmaciu, Carmen Mihaela [1 ]
Dinesh, Bhimareddy [2 ]
Pellerano, Morgan [1 ]
Diot, Sebastien [1 ]
Guidetti, Melanie [3 ]
Vollaire, Julien [3 ]
Bianco, Alberto [2 ]
Menard-Moyon, Cecilia [2 ]
Josserand, Veronique [3 ]
Morris, May C. [1 ]
机构
[1] Univ Montpellier, CNRS, Inst Biomol Max Mousseron, UMR5247, F-34093 Montpellier, France
[2] Univ Strasbourg, CNRS, ISIS, Immunol Immunopathol & Therapeut Chem UPR 3572, F-67000 Strasbourg, France
[3] Univ Grenoble Alpes, CNRS, Inst Avancee Biosci, INSERM,U1209,UMR 5309, F-38000 Grenoble, France
关键词
cancer; carbon nanotubes; CDK1; kinase; fluorescence; peptide biosensors;
D O I
10.1002/smll.202007177
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Probing the dynamics and quantifying the activities of intracellular protein kinases that coordinate cell growth and division and constitute biomarkers and pharmacological targets in hyperproliferative and pathological disorders remain a challenging task. Here engineering and characterization of a nanobiosensor of the mitotic kinase CDK1, through multifunctionalization of carbon nanotubes with a CDK1-specific fluorescent peptide reporter, are described. This original reporter of CDK1 activity combines the sensitivity of a fluorescent biosensor with the unique physico-chemical and biological properties of nanotubes for multifunctionalization and efficient intracellular penetration. The functional versatility of this nanobiosensor enables implementation to quantify CDK1 activity in a sensitive and dose-dependent fashion in complex biological environments in vitro, to monitor endogenous kinase in living cells and directly within tumor xenografts in mice by fluorescence imaging, thanks to a ratiometric quantification strategy accounting for response relative to concentration in space and in time.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] CDK1 AND CDK2 ACTIVITY IS A STRONG PREDICTOR OF RENAL CELL CANCER RECURRENCE
    Hongo, F.
    Takaha, N.
    Kimura, Y.
    Nakamura, T.
    Mikami, K.
    Nakayama, S.
    Matsushima, T.
    Ishihara, H.
    Sakai, T.
    Miki, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 138 - 139
  • [22] CDK1 and CDK2 activity is a strong predictor of renal cell cancer recurrence
    Hongo, Fumiya
    Takaha, Natsuki
    Kimura, Yasunori
    Nakamura, Terukazu
    Mikami, Kazuya
    Nakayama, Satoshi
    Matsushima, Tomoko
    Ishihara, Hideki
    Sakai, Toshiyuki
    Miki, Tsuneharu
    CANCER RESEARCH, 2011, 71
  • [23] CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence
    Hongo, Fumiya
    Takaha, Natsuki
    Oishi, Masakatsu
    Ueda, Takashi
    Nakamura, Terukazu
    Naitoh, Yasuyuki
    Naya, Yoshio
    Kamoi, Kazumi
    Okihara, Koji
    Matsushima, Tomoko
    Nakayama, Satoshi
    Ishihara, Hideki
    Sakai, Toshiyuki
    Miki, Tsuneharu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1240 - 1246
  • [24] Use of CDK1 and CDK2 activity to predict renal cell cancer recurrence
    Hongo, F.
    Takaha, N.
    Kimura, Y.
    Nakamura, T.
    Mikami, K.
    Nakayama, S.
    Shibayama, M.
    Ishihara, H.
    Sakai, T.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] CDK1 AND CDK2 ACTIVITY IS A STRONG PREDICTOR OF RENAL CELL CANCER RECURRENCE
    Hongo, Fumiya
    Takaha, Natsuki
    Kimura, Yasunori
    Nakamura, Terukazu
    Mikami, Kazuya
    Nakayama, Satoshi
    Matsushima, Tomoko
    Ishihara, Hideaki
    Sakai, Toshiyuki
    Miki, Tsuneharu
    JOURNAL OF UROLOGY, 2011, 185 (04): : E390 - E390
  • [26] Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine
    Garcia, Tamara B.
    Fosmire, Susan P.
    Porter, Christopher C.
    LEUKEMIA RESEARCH, 2018, 64 : 30 - 33
  • [27] Phosphorylation of Ubc9 by Cdk1 Enhances SUMOylation Activity
    Su, Yee-Fun
    Yang, Tsunghan
    Huang, Hoting
    Liu, Leroy F.
    Hwang, Jaulang
    PLOS ONE, 2012, 7 (04):
  • [28] CDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activity
    Zhang, Lin
    Chen, Xingcheng
    Stauffer, Seth
    Yang, Shuping
    Chen, Yuanhong
    Dong, Jixin
    ONCOTARGET, 2015, 6 (31) : 31399 - 31412
  • [29] Is unconventional secretion inhibited during cell division by Cdk1 activity?
    Tang, Bor Luen
    JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (05) : 915 - 916
  • [30] THE ANTITUMOR COMPOUND FOSTRIECIN CAUSES PREMATURE CHROMOSOME CONDENSATION WITHOUT CDK1 ACTIVITY IN HUMAN-CELLS AND INHIBITS CDK1 ACTIVITY AND MATURATION IN SEA STAR OOCYTES
    TUDAN, C
    PELECH, S
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 63 - 63